Chromosomal mutations responsible for fluoroquinolone resistance in Ureaplasma species in the United States

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 5, 2012, Pages 2780-2783

  Li, Xiao ^a   Crabb, Donna M ^b   Duffy, Lynn B ^b   Paralanov, Vanya ^c   Glass, John I ^c   Waites, Ken B ^b  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c J CRAIG VENTER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE (ATP HYDROLYSING) B; ERYTHROMYCIN; LEVOFLOXACIN; PROTEIN PARC; PROTEIN PARE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CHROMOSOME MUTATION; CONTROLLED STUDY; DNA POLYMORPHISM; GENE SEQUENCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; UNITED STATES; UREAPLASMA;

ANTI-BACTERIAL AGENTS; CHROMOSOMES, BACTERIAL; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, BACTERIAL; HUMANS; ISOENZYMES; LONGITUDINAL STUDIES; MICROBIAL SENSITIVITY TESTS; MUTATION; OFLOXACIN; SEQUENCE ANALYSIS, DNA; UNITED STATES; UREAPLASMA; UREAPLASMA INFECTIONS;

EID: 84860132940     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.06342-11     Document Type: Article

References (21)

1. Bebear CM, et al. 2000. In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized. Antimicrob. Agents Chemother. 44:2557-2560. (Pubitemid 30650917)
2. Beeton ML, Chalker VJ, Kotecha S, Spiller OB. 2009. Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism. J. Antimicrob. Chemother. 64:529-538.
3. Beeton ML, et al. 2009. Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance. Antimicrob. Agents Chemother. 53:2020-2027.
4. Clinical and Laboratory Standards Institute. 2011. Antimicrobial susceptibility testing of human mycoplasmas: approved guideline. CLSI document M43-A Clinical and Laboratory Standards Institute, Wayne, PA.
5. Duffy L, et al. 2006. Fluoroquinolone resistance in Ureaplasma parvum in the United States. J. Clin. Microbiol. 44:1590-1591.
6. Hooper DC. 1998. Bacterial topoisomerases, anti-topoisomerases, and anti-topoisomerase resistance. Clin. Infect. Dis. 27(Suppl 1):S54-S63. (Pubitemid 28375860)
7. Lapusan DL, Duffy L, Hamilos DL. 2001. Disseminated septic arthritis in a patient with common variable hypogammaglobulinemia. Ann. Allergy Asthma Immunol. 86:368-372. (Pubitemid 32332313)
8. Piddock LJ. 1999. Mechanisms of fluoroquinolone resistance: an update 1994-1998. Drugs 58(Suppl 2):11-18. (Pubitemid 29500079)
9. Roberts MC, Kenny GE. 1986. Dissemination of the tetM tetracycline resistance determinant to Ureaplasma urealyticum. Antimicrob. Agents Chemother. 29:350-352. (Pubitemid 16162957)
10. Schelonka RL, Waites KB. 2007. Ureaplasma infection and neonatal lung disease. Semin. Perinatol. 31:2-9. (Pubitemid 46273657)
11. Schmitz FJ, Higgins PG, Mayer S, Fluit AC, Dalhoff A. 2002. Activity of quinolones against gram-positive cocci: mechanisms of drug action and bacterial resistance. Eur. J. Clin. Microbiol. Infect. Dis. 21:647- 659.
12. Waites KB, Crouse DT, Cassell GH. 1993. Therapeutic considerations for Ureaplasma urealyticum infections in neonates. Clin. Infect. Dis. 17(Suppl 1):S208-S214. (Pubitemid 23227133)
13. Waites KB, Duffy LB, Schwartz S, Talkington DF. 2010. Mycoplasma and Ureaplasma, p 3.15.1-3.15.7. In Garcia L, Isenberg H (ed), Clinical Microbiology Procedures Handbook, 3rd ed. ASM Press, Washington, DC.
14. Waites KB, Katz B, Schelonka RL. 2005. Mycoplasmas and ureaplasmas as neonatal pathogens. Clin. Microbiol. Rev. 18:757-789. (Pubitemid 41504514)
15. Woese CR, Maniloff J, Zablen LB. 1980. Phylogenetic analysis of the mycoplasmas. Proc. Natl. Acad. Sci. U. S. A. 77:494-498. (Pubitemid 10126063)
16. Xia LN, et al. 2010. A survey of plasmid-mediated fluoroquinolone resistance genes from Escherichia coli isolates and their dissemination in Shandong, China. Foodborne Pathog. Dis. 7:207-215.
17. Xiao L, et al. 2011. Mutations in ribosomal proteins and ribosomal RNA confer macrolide resistance in human Ureaplasma spp. Int. J. Antimicrob. Agents 37:377-379.
18. Xiao L, et al. 2010. Detection and characterization of human Ureaplasma species and serovars by real-time PCR. J. Clin. Microbiol. 48:2715-2723.
19. Xiao L, et al. 2011. Extensive horizontal gene transfer in ureaplasmas from humans questions the utility of serotyping for diagnostic purposes. J. Clin. Microbiol. 49:2818-2826.
20. Xie X, Zhang J. 2006. Trends in the rates of resistance of Ureaplasma urealyticum to antibiotics and identification of the mutation site in the quinolone resistance-determining region in Chinese patients. FEMS Microbiol. Lett. 259:181-186. (Pubitemid 43828737)
21. Zhang W, Wu Y, Yin W, Yu M. 2002. Study of isolation of fluoroquinolone- resistant Ureaplasma urealyticum and identification of mutant sites. Chin. Med. J. 115:1573-1575. (Pubitemid 35282928)